SCHEMBL19084707

SCHEMBL19084707

CCOC(=O)c1c(NC(=O)OC(C)(C)C)oc2cc(Br)ccc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TBK1 Q9UHD2 1/20 0.45
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA9 Q16790 1/20 0.44
ALOX5 P09917 3/20 0.41
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
PRNP P04156 2/20 0.41
ALDH1A1 P00352 5/20 0.40
HPGD P15428 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
HTT P42858 1/20 0.40
GPR55 Q9Y2T6 1/20 0.40
HSD17B10 Q99714 2/20 0.39
HIF1A Q16665 1/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25946559 0.83 TBK1 (0.44) TBK1CA12CA1CA9ALOX5
SCHEMBL16505154 0.81 AAK1 (0.38) TBK1CA12CA1CA9MEN1
SCHEMBL25946552 0.77 TSHR (0.57) TBK1ALOX5MEN1KMT2AALDH1A1
SCHEMBL25946554 0.74 MAPK1 (0.53) TBK1ALOX5MEN1KMT2APRNP
SCHEMBL16504496 0.74 KDM4E (0.41) ALDH1A1HPGDSMN1; SMN2HTTHIF1A
SCHEMBL25946558 0.73 TBK1 (0.51) TBK1ALOX5MEN1KMT2APRNP
SCHEMBL16504630 0.73 ALDH1A1 (0.39) CA12CA1CA9MEN1KMT2A
SCHEMBL16505064 0.73 ALDH1A1 (0.39) CA12CA1CA9MEN1KMT2A
SCHEMBL18039335 0.71 TARBP2 (0.48) ALOX5KMT2AALDH1A1HPGDHSD17B10
SCHEMBL16522633 0.71 ALDH1A1 (0.37) CA12CA1CA9MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10000507-B2 Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors INCYTE CORPORATION (US) 2018-06-19 US disclosed
US-20170190716-A1 FURO- AND THIENO-PYRIDINE CARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS INCYTE CORPORATION 2017-07-06 US disclosed
US-20170190716-A1 FURO- AND THIENO-PYRIDINE CARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS INCYTE CORPORATION 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170190716-A1 FURO- AND THIENO-PYRIDINE CARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS PIM1, PIM2, PIM3 TBK1 146/4885CA12 4718/4885CA1 4770/4885
US-10000507-B2 Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors PIM1, PIM2, PIM3 TBK1 146/4885CA12 4718/4885CA1 4770/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.